326 related articles for article (PubMed ID: 8623923)
21. Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphomas but its differential expression in benign versus malignant follicles and monocytoid B-cell proliferations is of diagnostic value.
Wang T; Lasota J; Hanau CA; Miettinen M
APMIS; 1995 Sep; 103(9):655-62. PubMed ID: 7488387
[TBL] [Abstract][Full Text] [Related]
22. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
23. Bcl-6 protein expression by follicle center lymphomas. A marker for differentiating follicle center lymphomas from other low-grade lymphoproliferative disorders.
Raible MD; Hsi ED; Alkan S
Am J Clin Pathol; 1999 Jul; 112(1):101-7. PubMed ID: 10396291
[TBL] [Abstract][Full Text] [Related]
24. Genetic immunization: a new monoclonal antibody for the detection of BCL-6 protein in paraffin sections.
García JF; García JF; Maestre L; Lucas E; Sánchez-Verde L; Romero-Chala S; Piris MA; Roncador G
J Histochem Cytochem; 2006 Jan; 54(1):31-8. PubMed ID: 16046671
[TBL] [Abstract][Full Text] [Related]
25. The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas.
Paterson JC; Tedoldi S; Craxton A; Jones M; Hansmann ML; Collins G; Roberton H; Natkunam Y; Pileri S; Campo E; Clark EA; Mason DY; Marafioti T
Haematologica; 2006 Jun; 91(6):772-80. PubMed ID: 16769579
[TBL] [Abstract][Full Text] [Related]
26. Expression of bcl-2 oncogene product in primary non-Hodgkin's malignant lymphoma of the oral cavity.
Takahashi H; Kawazoe K; Fujita S; Okabe H; Hideshima K; Tsuda N; Tezuka F
Pathol Res Pract; 1996 Jan; 192(1):44-53. PubMed ID: 8685041
[TBL] [Abstract][Full Text] [Related]
27. Antigen retrieval for bcl-2 protein in formalin-fixed, paraffin-embedded sections.
Umemura S; Kawai K; Osamura RY; Tsutsumi Y
Pathol Int; 1995 Feb; 45(2):103-7. PubMed ID: 7742922
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of Mcl-1 and Bcl-2 proteins in normal and neoplastic lymph nodes.
Krajewski S; Bodrug S; Gascoyne R; Berean K; Krajewska M; Reed JC
Am J Pathol; 1994 Sep; 145(3):515-25. PubMed ID: 8080035
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.
Gambacorta M; Flenghi L; Fagioli M; Pileri S; Leoncini L; Bigerna B; Pacini R; Tanci LN; Pasqualucci L; Ascani S; Mencarelli A; Liso A; Pelicci PG; Falini B
Am J Pathol; 1996 Dec; 149(6):2023-35. PubMed ID: 8952536
[TBL] [Abstract][Full Text] [Related]
30. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
[TBL] [Abstract][Full Text] [Related]
31. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
32. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
Huebner-Chan D; Fernandes B; Yang G; Lim MS
Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.
Imam A; Stathopoulos E; Holland SL; Epstein AL; Taylor CR
Cancer Res; 1990 Mar; 50(5):1650-7. PubMed ID: 1689214
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
Marder RJ; Variakojis D; Silver J; Epstein AL
Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
[TBL] [Abstract][Full Text] [Related]
35. Bcl-2 protein in centrocytic lymphoma; a paraffin section study.
Swerdlow SH; Utz GL; Williams ME
Leukemia; 1993 Sep; 7(9):1456-8. PubMed ID: 8371594
[TBL] [Abstract][Full Text] [Related]
36. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues.
Cartun RW; Coles FB; Pastuszak WT
Am J Pathol; 1987 Dec; 129(3):415-21. PubMed ID: 3322020
[TBL] [Abstract][Full Text] [Related]
37. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.
Pezzella F; Tse AG; Cordell JL; Pulford KA; Gatter KC; Mason DY
Am J Pathol; 1990 Aug; 137(2):225-32. PubMed ID: 2201196
[TBL] [Abstract][Full Text] [Related]
38. Expression of Bcl-2 protein and Fas antigen in non-Hodgkin's lymphomas.
Kondo E; Yoshino T; Yamadori I; Matsuo Y; Kawasaki N; Minowada J; Akagi T
Am J Pathol; 1994 Aug; 145(2):330-7. PubMed ID: 7519826
[TBL] [Abstract][Full Text] [Related]
39. BCL-6: rearrangement and mutation in lymphoma.
Wagner SD; Kaeda JS
Methods Mol Med; 2005; 115():251-70. PubMed ID: 15998973
[TBL] [Abstract][Full Text] [Related]
40. Pax5 expression in non-Hodgkin's lymphomas and acute leukemias.
Zhang X; Lin Z; Kim I
J Korean Med Sci; 2003 Dec; 18(6):804-8. PubMed ID: 14676435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]